[en] Melarsoprol is the main drug used for the treatment of late-stage sleeping sickness, although it causes severe side-effects such as encephalopathy and polyneuropathy leading to death in some patients. Recent data suggest that melarsoprol and its active metabolite melarsenoxide interfere with thiamin transport and metabolism in E. coli and yeast, but there are no data concerning their possible effects on thiamin metabolism in mammalian cells. We tested both drugs on thiamin transport in cultured mouse neuroblastoma cells using C-14-labeled thiamin. Melarsoprol, competitively inhibits high-affinity thiamin transport in mouse neuroblastoma cells with a K-i of 44 mu mol/L. However, the active compound melarsenoxide has no inhibitory effect. This suggests that the side effects of melarsoprol treatment are unlikely to be due to inhibition of thiamin transport by melarsenoxide, its main metabolite in the brain.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Szyniarowski, Piotr
Bettendorff, Lucien ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Schweingruber, M. E.
Language :
English
Title :
The antitrypanosomal drug melarsoprol competitively inhibits thiamin uptake in mouse neuroblastoma cells
Bettendorff L, Wins P. Mechanism of thiamin transport in neuroblastoma cells: Inhibition of a high affinity earner by sodium channel activators and dependence of thiamine uptake on membrane potential and intracellular ATP. J Biol Chem. 1994;269:14379-85.
Blum J, Nkunku S, Burri C. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Trop Med Int Health. 2001;6:390-400.
Carter NS, Fairlamb AH. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 1993;361:173-6.
Diaz GA, Banikazemi M, Oishi K, Desnick RJ, Gelb BD. Mutations in a new gene encoding a thiamine transporter cause thiamin-responsive megaloblastic anaemia syndrome. Nat Genet. 1999;22:309-12.
Docampo R, Moreno SNJ. Current chemotherapy of human African trypanosomiasis. Parasitol Res. 2003;90:S10-3.
Dutta B, Huang W, Molero M, et al. Cloning of the human thiamin transporter, a member of the folate transporter family. J Biol Chem. 1999;45:31925-9.
Eudy JD, Spiegelstein O, Barber RC, Wlodarczyk BJ, Talbot J, Finnell RH. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. Mol Gen Metab. 2000;71:581-90.
Friedheim, EAH. Mel B in the treatment of human trypanosomiasis. Am J Trop Med. 1949;29:173-80.
Hubert D, Barrett MP. Uptake and mode of action of drugs used against sleeping sickness. Biochem Parasitol. 2000;61:1-5.
Keiser J, Ericsson O, Burri C. Investigations of the metabolites of the trypanocidal drug melarsoprol. Clin Pharmacol Ther. 2000;67:478-88.
Klebe RJ Ruddle FH. Neuroblastoma: cell culture analysis of a differentiating stem cell system. J Cell Biol. 1969;43:69a.
Mäser P, Sütterlin C, Kralli A, Kaminsky RA. A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science. 1999;285:242-44.
Mäser P, Lüscher A, Kaminsky RA. Drug transport and drug resistance in African trypanosomes. Drug Resist Update. 2003;6:281-90.
Nok AJ. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res. 2003;90:71-9.
Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977;83:346-56.
Rajgopal A, Edmondson A, Goldman D, Zhao R. SLC19A3 encodes a second thiamin transporter ThTr2. Biochim Biophys Acta. 2001;1537:175-8.
Said HM, Balamurugan K, Subramanian VS, Marchant JS. Expression and functional contribution of hTHTR-2 in thiamine absorption in human intestine. Am J Physiol Gastrointest Liver Physiol. 2004;286:G491-8.
Schweingruber ME. The melaminophenyl arsenicals melarsoprol and melarsenoxide interfere with thiamin metabolism in the fission yeast Schizosaccharomyces pombe. Antimicrob Agents Chemother. 2004;48:3268-71.
